Ocugen made a covid vaccine.
Ocugen has 100% short utilization in IBKR
Ocugen bounced off fib the other day closing the gap + it has a cup and handle, + the company hasn't fundamentally changed since it rocketed to $20... Aside from minor dilution.
Ocugen has a target >$10 from analysts.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.